2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyBernard J. Gersh, Clyde W. Yancy, Barry J. Maron et al.|Circulation|2011Cited by 2.1k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic CardiomyopathyBernard J. Gersh, Clyde W. Yancy, Barry J. Maron et al.|Journal of the American College of Cardiology|2011Cited by 1.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive SummaryBernard J. Gersh, Clyde W. Yancy, Barry J. Maron et al.|Circulation|2011Cited by 820
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathyBhaswati Pandit, Bruce D. Gelb, Cesare Rossi et al.|Nature Genetics|2007Cited by 702
Noninvasive estimation of left ventricular filling pressure by e/e′ is a powerful predictor of survival after acute myocardial infarctionGraham S. Hillis, Jae K. Oh, Jacob Eifer Møller et al.|Journal of the American College of Cardiology|2004Cited by 541